Critical Comparison: NAYA Biosciences (NASDAQ:NAYA) versus Acutus Medical (NASDAQ:AFIB)

NAYA Biosciences (NASDAQ:NAYA) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, analyst recommendations and institutional ownership.

Earnings & Valuation

This table compares NAYA Biosciences and Acutus Medical”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NAYA Biosciences	$6.23 million	0.09	-$8.03 million	N/A	N/A
Acutus Medical	$7.16 million	0.01	-$81.66 million	N/A	N/A

NAYA Biosciences has higher earnings, but lower revenue than Acutus Medical.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for NAYA Biosciences and Acutus Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NAYA Biosciences	0	0	1	0	3.00
Acutus Medical	0	0	0	0	0.00

NAYA Biosciences currently has a consensus target price of $24.00, suggesting a potential upside of 2,677.78%. Given NAYA Biosciences’ stronger consensus rating and higher probable upside, research analysts clearly believe NAYA Biosciences is more favorable than Acutus Medical.

Profitability

This table compares NAYA Biosciences and Acutus Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NAYA Biosciences	-119.91%	N/A	-41.72%
Acutus Medical	-272.74%	-311.64%	-11.57%

Insider & Institutional Ownership

12.0% of NAYA Biosciences shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 1.8% of NAYA Biosciences shares are held by insiders. Comparatively, 5.2% of Acutus Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Volatility and Risk

NAYA Biosciences has a beta of 2.03, indicating that its stock price is 103% more volatile than the S&P 500. Comparatively, Acutus Medical has a beta of -0.34, indicating that its stock price is 134% less volatile than the S&P 500.

Summary

NAYA Biosciences beats Acutus Medical on 8 of the 12 factors compared between the two stocks.

About NAYA Biosciences

NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.

About Acutus Medical

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.